Agriculture, rural development, and related agencies appropriations for 1982: hearings before a subcommittee of the Committee on Appropriations, House of Representatives, Ninety-seventh Congress, first session, Issue 8U.S. Government Printing Office, 1981 |
From inside the book
Results 1-5 of 100
Page 4
... Safety , Div . of Veterinary Medical Review , Bureau of Veterinary Medicine , Food & Drug Administration , U.S. Dept. of Health , Education & Welfare , Rockville , Md . August 1970 to July 1972 . 8. Special Assistant to the Director ...
... Safety , Div . of Veterinary Medical Review , Bureau of Veterinary Medicine , Food & Drug Administration , U.S. Dept. of Health , Education & Welfare , Rockville , Md . August 1970 to July 1972 . 8. Special Assistant to the Director ...
Page 7
... safety and effectiveness before they are approved for marketing . We also set standards to make certain that drugs are of sufficient potency and purity , and that they are properly labeled for their approved use . Another area that is ...
... safety and effectiveness before they are approved for marketing . We also set standards to make certain that drugs are of sufficient potency and purity , and that they are properly labeled for their approved use . Another area that is ...
Page 18
... safety of aminopyrine and its use was restricted to serious or life - threatening situations where salicylates or similar drugs were known to be ineffective , contraindicated , or not tolerated . It is unlikely that aminopyrine or its ...
... safety of aminopyrine and its use was restricted to serious or life - threatening situations where salicylates or similar drugs were known to be ineffective , contraindicated , or not tolerated . It is unlikely that aminopyrine or its ...
Page 22
... safety data availa- ble to FDA and they concluded the side effects were sufficient to restrict use to investigational circumstances until its therapeutic effect could be determined . So , it is not as though we were making decisions ...
... safety data availa- ble to FDA and they concluded the side effects were sufficient to restrict use to investigational circumstances until its therapeutic effect could be determined . So , it is not as though we were making decisions ...
Page 34
... safety and effectiveness . With the evolution of medical and scientif- ic knowledge and technology , the kinds of studies conducted to determine safety and effectiveness are more sophisticated and re- quire more time and talent to ...
... safety and effectiveness . With the evolution of medical and scientif- ic knowledge and technology , the kinds of studies conducted to determine safety and effectiveness are more sophisticated and re- quire more time and talent to ...
Other editions - View all
Common terms and phrases
action activities additional aflatoxin agency agency's amended ampicillin analysis analyzed animal drugs appropriate approved benzodiazepines budget Bureau business day carcinogen chemical Chicago Mercantile Exchange cimetidine clinical Committee Commodity compliance Conduct consumer contain Continue contract cosmetic costs delivery month digoxin dispensers distribution Drug Administration Drug Applications effects established Estimated evaluation FDA's Federal Register feed Food and Drug Food Safety FSQS funds grade guidelines HOUSTON human implementation increase industry initial inspection investigations labeling laboratory manufacturers meat and poultry medical devices methods methoxsalen monitoring NOVITCH orphan drugs patient package inserts percent pesticide pharmacists pharmacy phenytoin potential PPIs prescription drug Price Fluctuation problems procedures proposed regulations regulatory reports request requirements residue response revised risk samples Service SODIUM specific standards studies submitted testing thiazide tion toxic trading USDA vaccines warfarin WHITTEN